Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Central Texas Neurology Consultants (CTNC) is a premier neurology practice and clinical research center based in Round Rock, Texas, specializing in the diagnosis and treatment of complex neurological conditions. The organization is widely recognized as a leading site for Phase I through IV clinical trials, particularly in the field of Multiple Sclerosis, where it has played a significant role in the development of numerous FDA-approved therapies. Led by a team of board-certified neurologists, CTNC combines high-quality patient care with a robust research infrastructure that collaborates with global pharmaceutical and biotechnology companies. The center's research division focuses on advancing treatments for neurodegenerative diseases, including Alzheimer's and Parkinson's, as well as neuromuscular and seizure disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central Texas Neurology Consultants.